| Competitor Analysis: Heat shock protein 90 (Hsp90) Inhibitors | Digitalby La Merie S.L. (Author)
| List Price: | $175.00 | | | Available: | Available for download now |
| | Binding: | Digital | | Publisher: | MarketResearch.com | | Page Count: | 7 Pages | | Publication Date: | May 30, 2008 |
|
EDITORIAL REVIEWS |
Product Description
The Competitive Intelligence Report Heat shock protein 90 (Hsp90) Inhibitors updated as of May 2008 provides a competitor analysis in the development pipeline of novel small molecules targeting the heat shock protein 90 (Hspo90) chaperone for treatment of cancer. Among the companies active in t he R&D field ofHsp90 inhibitors are Kosan Bioscience, MedImmune and many others. The report includes a compilation of current active projects in research and development of Hsp90 Inhibitors. Competitor projects are listed in a tabular format providing Information on: Drug Codes, Target / Mechanism of Action, Class of Compound, Company, Therapeutic area, Indication, R&D Stage and additional comments with a hyperlink leading to the source of information. |
|
